Navigation Links
Schering-Plough CEO Buys $2 Million in Common Shares
Date:4/24/2008

KENILWORTH, N.J., April 24 /PRNewswire-FirstCall/ -- Schering-Plough Corporation announced today that Chairman and CEO Fred Hassan purchased just over $2 million of Schering-Plough common stock, or 110, 000 shares at an average purchase price of $18.26 per share.

"As I said when I announced my intention to purchase these shares in January, this investment in Schering-Plough reflects my long-term confidence in the company, its products -- including ZETIA and VYTORIN -- and our late- stage pipeline," said Hassan.

Hassan has said on January 18 that he intended to purchase the shares as soon as the transaction received legal clearance. That clearance was issued this morning, based upon first quarter earnings having been reported yesterday.

Full details of the purchase will be reported on a Form 4 filed with the SEC and available on Schering-Plough's Web site today or tomorrow.

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is http://www.schering-plough.com.


'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Schering-Plough Announces Planned Divestiture of Select Animal Health Products in Europe
2. Schering-Plough Reports Financial Results for First Quarter of 2008
3. Schering-Plough Schedules Conference Call and Webcast for 2008 First Quarter Earnings
4. Schering-Plough Launches Productivity Transformation Program To Confront New Challenges
5. Centocor, Inc. and Schering-Plough Submit Application Requesting Approval of Golimumab in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
6. Schering-Plough Announces Filing of U.S. Application for OTC ZEGERID(R)
7. Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
8. Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
9. Schering-Plough Announces Organizational Changes at Schering-Plough Research Institute
10. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
11. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... 2014 Sinovac Biotech Ltd. (Nasdaq: SVA ... China , today announced that it will release its ... 2014, after market close on Thursday, August 14, 2014 EDT. ... market opening on Friday, August 15, 2014, at 8:00 a.m. ... Time) to review the Company,s financial results and provide an ...
(Date:7/24/2014)... OAK RIDGE, Tenn., July 24, 2014 -- A novel ... at the Department of Energy,s Oak Ridge National Laboratory ... known for its unusual physical and electrochemical properties. ... examined how oxygen affects the surface of a perovskite ... electronic behavior. The new avenue to understand surface behavior ...
(Date:7/24/2014)... July 24, 2014  Now available is a stem ... Rehealth Regenerative Therapies , located in Guadalajara, ... active people a new health option: stem cell ... age, countless patients suffer from joint and muscle injuries ... muscle tears, torn rotator cuff, tennis elbow, and knee ...
(Date:7/24/2014)... 24, 2014  ECC West Africa, LLC (ECC) signed ... with University College Hospital (UCH) Ibadan Board of Management ... finance, design, construct, and operate and maintain a new, ... . Under the first of the 4-phase project, ECC ... funding applications. UCH Ibadan intends to finance and develop ...
Breaking Biology Technology:Sinovac to Host Conference Call to Report Second Quarter 2014 Unaudited Financial Results 2ORNL study reveals new characteristics of complex oxide surfaces 2Stem Cells In Sports Injuries, Joints And Muscular Pain 2Stem Cells In Sports Injuries, Joints And Muscular Pain 3ECC Signs a Contract for the Finance, Design, and Construction of a Premier Cancer Institute in Ibadan, Nigeria 2
... 2011 Nile Therapeutics, Inc. (NASDAQ: ... heart failure patients, today announced that the Company,s securities will ... open of business on May 12, 2011.  The Company expects ... on the OTCQB Marketplace following the suspension of trading on ...
... MOUNTAIN VIEW, Calif., May 11, 2011 ... Biosciences (SBI) , both leaders in genetic modification technology, have ... biotechnology companies involving Transposagen,s piggyBac ™ technology. ... Genetic Modification System enables researchers ...
... 11, 2011 Novavax, Inc. (Nasdaq: NVAX ... by the Tech Council of Maryland (TCM), the largest ... communities of Maryland.  Novavax was recognized as the firm ... community and for its presence and leadership in Maryland. ...
Cached Biology Technology:Nile Therapeutics to Transition to OTCQB Marketplace 2Nile Therapeutics to Transition to OTCQB Marketplace 3Transposagen's piggyBac™ Vectors to be Distributed by System Biosciences 2Transposagen's piggyBac™ Vectors to be Distributed by System Biosciences 3Novavax Named Biotechnology Firm of the Year by Tech Council of Maryland 2
(Date:7/27/2014)... over 18,000 patients, scientists have identified more than ... disease, including six that had not been previously ... , was partially funded by the National Institutes ... in NIH laboratories. , "Unraveling the genetic underpinnings ... mechanisms involved in this complex disease, and hopefully, ...
(Date:7/25/2014)... summer and some of the smoke from those fires is ... by the Moderate Resolution Imaging Spectroradiometer (MODIS) aboard the Aqua ... descended over the Great Lakes region of the United States. ... July 23, 2014 (first image feature highlighted below) clearly shows ... In the image, it is over Manitoba and ...
(Date:7/25/2014)... associate professor of biomedical engineering at the University ... tissue engineering and artificial organ development., "Introduction to ... guide to entering into the field of artificial ... of biomedical engineering at UH, served as a ... while there are other published books on the ...
Breaking Biology News(10 mins):NIH scientists find 6 new genetic risk factors for Parkinson's 2University of Houston researcher publishes textbook on tissue engineering 2
... available in German . Halle/Saale, Potsdam, ... species could lose parts of its current range, a ... Research (UFZ), the Potsdam Institute for Climate Impact Research ... distributions will be rearranged as a result of climate ...
... is no passive spectator of biological processes; it is an ... which the actions of the solvent play a key role. ... has been on observation of the protein backbone and its ... have now been able to detect changes in the proteinwater ...
... to search for food according to how stocked their ... London. When bumblebees return to the nest from ... encourages their nest mates to also go out and ... elicited a standard response from all bees. But new ...
Cached Biology News:Climate change threatens 1 in 5 plant species 2Keeping an eye on the surroundings 2Smells like bees' spirit 2
Mouse monoclonal [0.T.81] to Lac1 ( Abpromise for all tested applications). Antigen: Recombinant TrpE fusion protein containing full length E. coli Lac1....
Peptide-affinity Purified Polyclonal Antibody to ICEBERG Peptide with sequence EEDPQLASKMGLH, from C Terminus of the protein sequence according to NP_067546...
3T3 cells (RSV-transformed) Source: Cell Lysate Form: Ready to Use Application: Western Blotting Control...
A431 cells stimulated with EGF Source: Cell Lysate Form: Ready to Use Application: Western Blotting Control...
Biology Products: